BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schlitter AM, Esposito I. Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancers (Basel). 2010;2:2001-2010. [PMID: 24281214 DOI: 10.3390/cancers2042001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Z, Yin T, Qin T, Pan S, Wang M, Zhang H, Qin R. Comparison of laparoscopic versus open pancreaticoduodenectomy in patients with resectable pancreatic ductal adenocarcinoma: A propensity score-matching analysis of long-term survival. Pancreatology 2021:S1424-3903(21)00652-9. [PMID: 34969601 DOI: 10.1016/j.pan.2021.12.005] [Reference Citation Analysis]
2 Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH, Neoptolemos JP. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022. [PMID: 27158978 DOI: 10.1038/nrdp.2016.22] [Cited by in Crossref: 657] [Cited by in F6Publishing: 617] [Article Influence: 109.5] [Reference Citation Analysis]
3 Pal S, George J, Singh AN, Mathur S, Dash NR, Garg P, Sahni P, Chattopadhyay T. Posterior Superior Mesenteric Artery (SMA) First Approach vs. Standard Pancreaticoduodenectomy in Patients with Resectable Periampullary Cancers: a Prospective Comparison Focusing on Circumferential Resection Margins. J Gastrointest Canc 2018;49:252-9. [DOI: 10.1007/s12029-017-9933-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Kwon J, Song KB, Park SY, Shin D, Hong S, Park Y, Lee W, Lee JH, Hwang DW, Kim SC. Comparison of Minimally Invasive Versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis. Cancers (Basel) 2020;12:E982. [PMID: 32326595 DOI: 10.3390/cancers12040982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zhang L, Zou X, Huang J, Fan J, Sun X, Zhang B, Zheng B, Guo C, Fu D, Yao L, Ji M. Label-Free Histology and Evaluation of Human Pancreatic Cancer with Coherent Nonlinear Optical Microscopy. Anal Chem 2021;93:15550-8. [PMID: 34751027 DOI: 10.1021/acs.analchem.1c03861] [Reference Citation Analysis]
6 Xu J, Chen Y, Chen H, Hong Z, Shi Z, Zhuo S, Zhu X, Chen J. Identifying the neck margin status of ductal adenocarcinoma in the pancreatic head by multiphoton microscopy. Sci Rep 2017;7:4586. [PMID: 28676646 DOI: 10.1038/s41598-017-04771-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Liu C, Tian X, Xie X, Gao H, Zhuang Y, Yang Y. Comparison of Uncinate Process Cancer and Non-Uncinate Process Pancreatic Head Cancer. J Cancer 2016;7:1242-9. [PMID: 27390599 DOI: 10.7150/jca.15062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Michalski CW, Kong B, Jäger C, Kloe S, Beier B, Braren R, Esposito I, Erkan M, Friess H, Kleeff J. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience. BMC Surg 2015;15:100. [PMID: 26296752 DOI: 10.1186/s12893-015-0086-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
9 Safi SA, Rehders A, Haeberle L, Fung S, Lehwald N, Esposito I, Ziayee F, Krieg A, Knoefel WT, Fluegen G. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors? Surgery 2021:S0039-6060(21)00666-8. [PMID: 34392977 DOI: 10.1016/j.surg.2021.06.045] [Reference Citation Analysis]
10 Nuckles BW, Lam K, Young KA, Dove JT, Shabahang MM, Blansfield JA. Quality Improvement for Surgical Resection of Pancreatic Head Adenocarcinoma : Hospital and Surgeon Predictors of Higher Than Expected R1 Resection Using the National Cancer Database. Am Surg 2021;87:396-403. [PMID: 32993353 DOI: 10.1177/0003134820950281] [Reference Citation Analysis]
11 Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, Sauvanet A, Autret A, Turrini O, Monges-Ranchin G. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB (Oxford). 2014;16:20-33. [PMID: 23464850 DOI: 10.1111/hpb.12061] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 11.7] [Reference Citation Analysis]
12 Demir IE, Jäger C, Schlitter AM, Konukiewitz B, Stecher L, Schorn S, Tieftrunk E, Scheufele F, Calavrezos L, Schirren R, Esposito I, Weichert W, Friess H, Ceyhan GO. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer. Ann Surg 2018;268:1058-68. [PMID: 28692477 DOI: 10.1097/SLA.0000000000002345] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 17.7] [Reference Citation Analysis]
13 Lutz MP, Zalcberg JR, Ducreux M, Aust D, Bruno MJ, Büchler MW, Delpero JR, Gloor B, Glynne-Jones R, Hartwig W, Huguet F, Laurent-Puig P, Lordick F, Maisonneuve P, Mayerle J, Martignoni M, Neoptolemos J, Rhim AD, Schmied BM, Seufferlein T, Werner J, van Laethem JL, Otto F. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. Eur J Cancer 2017;79:41-9. [PMID: 28460245 DOI: 10.1016/j.ejca.2017.03.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
14 Toesca DAS, Koong AJ, Poultsides GA, Visser BC, Haraldsdottir S, Koong AC, Chang DT. Management of Borderline Resectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys 2018;100:1155-74. [PMID: 29722658 DOI: 10.1016/j.ijrobp.2017.12.287] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
15 Kim KS, Kwon J, Kim K, Chie EK. Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis. Cancer Res Treat. 2017;49:824-833. [PMID: 27561314 DOI: 10.4143/crt.2016.336] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
16 Pollheimer MJ, Langner C. [Pathology of the R1 classification in visceral cancer surgery]. Chirurg 2017;88:731-9. [PMID: 28593347 DOI: 10.1007/s00104-017-0448-6] [Reference Citation Analysis]
17 Adsay NV, Basturk O, Saka B, Bagci P, Ozdemir D, Balci S, Sarmiento JM, Kooby DA, Staley C, Maithel SK, Everett R, Cheng JD, Thirabanjasak D, Weaver DW. Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors. Am J Surg Pathol 2014;38:480-93. [PMID: 24451278 DOI: 10.1097/PAS.0000000000000165] [Cited by in Crossref: 64] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
18 Ratnayake B, Savastyuk AY, Nayar M, Wilson CH, Windsor JA, Roberts K, French JJ, Pandanaboyana S. Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis. J Clin Med 2020;9:E2132. [PMID: 32640720 DOI: 10.3390/jcm9072132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Borzomati D, Perrone G, Nappo G, Valeri S, Amato M, Petitti T, Muda AO, Coppola R. Microscopic Residual Tumor After Pancreaticoduodenectomy: Is Standardization of Pathological Examination Worthwhile? Pancreas 2016;45:748-54. [DOI: 10.1097/mpa.0000000000000540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Markov P, Satoi S, Kon M. Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci 2016;23:523-32. [PMID: 27524388 DOI: 10.1002/jhbp.374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
21 Kim SJ, Kim MJ, Han JS, Sung YN, An S, Lee JH, Song KB, Hwang DW, Lee SS, Cho H, Kim SC, Eshleman JR, Hong SM. Prediction of Recurrence With KRAS Mutational Burden Using Ultrasensitive Digital Polymerase Chain Reaction of Radial Resection Margin of Resected Pancreatic Ductal Adenocarcinoma. Pancreas 2019;48:400-11. [PMID: 30747828 DOI: 10.1097/MPA.0000000000001255] [Reference Citation Analysis]
22 Dolay K, Malya FU, Akbulut S. Management of pancreatic head adenocarcinoma: From where to where? World J Gastrointest Surg 2019; 11(3): 143-154 [PMID: 31057699 DOI: 10.4240/wjgs.v11.i3.143] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Ren L, Mota Reyes C, Friess H, Demir IE. Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit? Langenbecks Arch Surg 2020;405:879-87. [PMID: 32776259 DOI: 10.1007/s00423-020-01946-4] [Reference Citation Analysis]
24 Ghaneh P, Kleeff J, Halloran CM, Raraty M, Jackson R, Melling J, Jones O, Palmer DH, Cox TF, Smith CJ, O'Reilly DA, Izbicki JR, Scarfe AG, Valle JW, McDonald AC, Carter R, Tebbutt NC, Goldstein D, Padbury R, Shannon J, Dervenis C, Glimelius B, Deakin M, Anthoney A, Lerch MM, Mayerle J, Oláh A, Rawcliffe CL, Campbell F, Strobel O, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Ann Surg 2019;269:520-9. [PMID: 29068800 DOI: 10.1097/SLA.0000000000002557] [Cited by in Crossref: 95] [Cited by in F6Publishing: 48] [Article Influence: 31.7] [Reference Citation Analysis]
25 Pouypoudat C, Buscail E, Cossin S, Cassinotto C, Terrebonne E, Blanc JF, Smith D, Marty M, Dupin C, Laurent C, Dabernat S, Chiche L, Vendrely V. FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre. Dig Liver Dis 2019;51:1043-9. [PMID: 31000479 DOI: 10.1016/j.dld.2019.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
26 de W Marsh R, Talamonti MS, Baker MS, Posner M, Roggin K, Matthews J, Catenacci D, Kozloff M, Polite B, Britto M, Wang C, Kindler H. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol 2018;117:354-62. [PMID: 29044544 DOI: 10.1002/jso.24872] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
27 Kommalapati A, Tella SH, Goyal G, Ma WW, Mahipal A. Contemporary Management of Localized Resectable Pancreatic Cancer. Cancers (Basel) 2018;10:E24. [PMID: 29361690 DOI: 10.3390/cancers10010024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
28 Kim J, Lee YS, Hwang IK, Kang BK, Cho JY, Yoon YS, Han HS, Hwang JH. Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma. J Korean Med Sci 2015;30:259-63. [PMID: 25729247 DOI: 10.3346/jkms.2015.30.3.259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
29 Safi SA, Haeberle L, Heuveldop S, Kroepil P, Fung S, Rehders A, Keitel V, Luedde T, Fuerst G, Esposito I, Ziayee F, Antoch G, Knoefel WT, Fluegen G. Pre-Operative MDCT Staging Predicts Mesopancreatic Fat Infiltration-A Novel Marker for Neoadjuvant Treatment? Cancers (Basel) 2021;13:4361. [PMID: 34503170 DOI: 10.3390/cancers13174361] [Reference Citation Analysis]
30 Safi SA, Haeberle L, Fluegen G, Lehwald-Tywuschik N, Krieg A, Keitel V, Luedde T, Esposito I, Rehders A, Knoefel WT. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. Pancreatology 2021;21:787-95. [PMID: 33775563 DOI: 10.1016/j.pan.2021.02.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ocaña J, Sanjuanbenito A, García A, Molina JM, Lisa E, Mendía E, Saavedra C, Lobo E. Relevance of positive resection margins in ductal pancreatic adenocarcinoma and prognostic factors. Cir Esp (Engl Ed) 2020;98:85-91. [PMID: 31395275 DOI: 10.1016/j.ciresp.2019.06.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Ivanovic AM, Alessandrino F, Maksimovic R, Micev M, Ostojic S, Gore RM, Mortele KJ. Pathologic Subtypes of Ampullary Adenocarcinoma: Value of Ampullary MDCT for Noninvasive Preoperative Differentiation. AJR Am J Roentgenol. 2017;208:W71-W78. [PMID: 28095024 DOI: 10.2214/ajr.16.16723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
33 Schlitter AM, Häberle L, Richter C, Huss R, Esposito I. [Standardized diagnosis of pancreatic head carcinoma]. Pathologe 2021;42:453-63. [PMID: 34357472 DOI: 10.1007/s00292-021-00971-4] [Reference Citation Analysis]
34 Jung JP, Zenati MS, Hamad A, Hogg ME, Simmons RL, Zureikat AH, Zeh HJ, Boone BA. Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma? HPB (Oxford) 2019;21:679-86. [PMID: 30501987 DOI: 10.1016/j.hpb.2018.10.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Gómez-mateo MC, Sabater-ortí L, Ruiz-montesinos I, Ferrández-izquierdo A. Pathology Reporting of Resected Pancreatic/Periampullary Cancer Specimen. In: Tewari M, editor. Surgery for Pancreatic and Periampullary Cancer. Singapore: Springer; 2018. pp. 247-80. [DOI: 10.1007/978-981-10-7464-6_26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Tampi CS, Nilkanth S, Jagannath P. Reporting the margin in pancreaticoduodenectomies: R0 versus R1. Indian J Gastroenterol 2017;36:81-7. [PMID: 28417289 DOI: 10.1007/s12664-017-0742-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
37 Shin H, Song KB, Kim YI, Lee YJ, Hwang DW, Lee JH, Shin SH, Kwon J, Alshammary S, Park G, Park Y, Lee SJ, Kim SC. Propensity score-matching analysis comparing laparoscopic and open pancreaticoduodenectomy in elderly patients. Sci Rep 2019;9:12961. [PMID: 31506513 DOI: 10.1038/s41598-019-49455-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
38 Zang C, Li S, Chi B, Chen S, Ye Z. An intraductal papillary mucinous neoplasm associated tubular adenocarcinoma with sarcomatoid component: A case report. Radiol Case Rep 2021;16:3494-8. [PMID: 34539943 DOI: 10.1016/j.radcr.2021.08.040] [Reference Citation Analysis]
39 Soer E, Brosens L, van de Vijver M, Dijk F, van Velthuysen ML, Farina-Sarasqueta A, Morreau H, Offerhaus J, Koens L, Verheij J. Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens. Virchows Arch. 2018;472:533-543. [PMID: 29589102 DOI: 10.1007/s00428-018-2321-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
40 Häberle L, Esposito I. Circumferential resection margin (CRM) in pancreatic cancer. Surgery in Practice and Science 2020;1:100006. [DOI: 10.1016/j.sipas.2020.100006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Chandrasegaram MD, Goldstein D, Simes J, Gebski V, Kench JG, Gill AJ, Samra JS, Merrett ND, Richardson AJ, Barbour AP. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg. 2015;102:1459-1472. [PMID: 26350029 DOI: 10.1002/bjs.9892] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 15.4] [Reference Citation Analysis]
42 Rahy-Martín AC, Cruz-Benavides F, Sánchez-Lauro M, Rodríguez-Méndez Á, San Miguel Í, Lara P, Marchena-Gómez J. Intraoperative radiotherapy with the Intrabeam® device for the treatment of resectable pancreatic adenocarcinoma. Cir Esp (Engl Ed) 2018;96:482-7. [PMID: 30297032 DOI: 10.1016/j.ciresp.2018.04.014] [Reference Citation Analysis]
43 Bal M, Rane S, Talole S, Ramadwar M, Deodhar K, Patil P, Goel M, Shrikhande S. Tumour origin and R1 rates in pancreatic resections: towards consilience in pathology reporting. Virchows Arch 2018;473:293-303. [PMID: 30091124 DOI: 10.1007/s00428-018-2429-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
44 Schlitter AM, Esposito I. [Pathology and classification of intraductal papillary mucinous neoplasms of the pancreas]. Chirurg. 2012;83:110-115. [PMID: 22271052 DOI: 10.1007/s00104-011-2181-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, Knight J, El-Rayes B, Kooby D, Sarmiento J, Muraki T, Oliva I, Bandyopadhyay S, Akkas G, Goodman M, Reid MD, Krasinskas A, Everett R, Adsay V. Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant. Ann Surg Oncol 2016;23:2010-8. [PMID: 26832882 DOI: 10.1245/s10434-016-5093-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 11.5] [Reference Citation Analysis]
46 Joliat GR, Petermann D, Demartines N, Schäfer M. External assessment of the Early Mortality Risk Score in patients with adenocarcinoma undergoing pancreaticoduodenectomy. HPB (Oxford) 2015;17:605-10. [PMID: 25906918 DOI: 10.1111/hpb.12422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
47 Coppola R, Cartillone M, Borzomati D, Nappo G, Valeri S, Petitti T, Perrone G. Surgical margins for duodenopancreatectomy. Updates Surg 2016;68:279-85. [DOI: 10.1007/s13304-016-0404-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Paiella S, Sandini M, Gianotti L, Butturini G, Salvia R, Bassi C. The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2016;42:616-624. [PMID: 26916137 DOI: 10.1016/j.ejso.2016.02.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
49 Kakar S, Pawlik TM, Allen PJ, Vauthey J. Exocrine Pancreas. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 337-47. [DOI: 10.1007/978-3-319-40618-3_28] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]